OR WAIT null SECS
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
FDA is seeking $7.2 billion to enhance food safety and advance medical product availability.
On March 9, 2023, FDA announced that it is requesting $7.2 billion as part of the president’s fiscal year 2024 budget. The request includes an increase of $372 million in budget authority and a $150 million increase in user fees.
The funding will allow the agency to continue to leverage new and emerging technologies, recruit and support a skilled workforce, and adapt oversight to new production and business models. This would have an immediate impact on food, tobacco, and medical product safety in the United States, while also preparing the agency to address rapid innovation across the food and medical products fields.
“This year’s funding request builds on our accomplishments and lessons learned over the past year and adds new funding to continue modernizing [FDA] and its capabilities for the future. We continue to deliver on a wide range of priorities and have strategically focused our request to ensure our program areas have the funding they need to operate with the highest success for the good of public health,” said FDA Commissioner Robert M. Califf in a press release. “Our investments to strengthen medical product safety and availability, along with funding for vital oversight of tobacco products continue to be a central focus. The budget also provides a historic investment to strengthen [FDA’s] food safety and nutrition capacity—especially for infants and young children, demonstrating the Administration’s ongoing commitment to these responsibilities. As always, our foremost focus is on the well-being of patients and consumers, and we look forward to continuing our work with Congress to help meet the critical public health challenges ahead.”